DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
| Autor: | Martinez-Marti, A., Felip, E. *, Matito, J., Mereu, E., Navarro, A., Cedrés, S., Pardo, N., Martinez de Castro, A., Remon, J., Miquel, J.M., Guillaumet-Adkins, A., Nadal, E., Rodriguez-Esteban, G., Arqués, O., Fasani, R., Nuciforo, P., Heyn, H., Villanueva, A., Palmer, H.G., Vivancos, A. ** |
|---|---|
| Zdroj: | In Annals of Oncology October 2017 28(10):2451-2457 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|